AAAAAA

   
Results: 1-16 |
Results: 16
FREQUENCY OF GERMLINE AND SOMATIC BRCA1 MUTATIONS IN OVARIAN-CANCER
Authors: BERCHUCK A HERON KA CARNEY ME LANCASTER JM FRASER EG VINSON VL DEFFENBAUGH AM MIRON A MARKS JR FUTREAL PA FRANK TS
Citation: A. Berchuck et al., FREQUENCY OF GERMLINE AND SOMATIC BRCA1 MUTATIONS IN OVARIAN-CANCER, Clinical cancer research, 4(10), 1998, pp. 2433-2437
ABERRANT SPLICING OF THE TSG101 TUMOR-SUPPRESSOR GENE IN HUMAN BREASTAND OVARIAN CANCERS
Authors: CARNEY ME MAXWELL L LANCASTER JM GUMBS C MARKS J BERCHUCK A FUTREAL PA
Citation: Me. Carney et al., ABERRANT SPLICING OF THE TSG101 TUMOR-SUPPRESSOR GENE IN HUMAN BREASTAND OVARIAN CANCERS, Journal of the Society for Gynecologic Investigation, 5(5), 1998, pp. 281-285
FAMILIAL BREAST-OVARIAN CANCER SYNDROMES - BRCA1 AND BRCA2
Authors: BERCHUCK A CARNEY M LANCASTER JM MARKS J FUTREAL AP
Citation: A. Berchuck et al., FAMILIAL BREAST-OVARIAN CANCER SYNDROMES - BRCA1 AND BRCA2, Clinical obstetrics and gynecology, 41(1), 1998, pp. 157-166
PROGESTERONE-RECEPTOR GENE POLYMORPHISM AND RISK FOR BREAST AND OVARIAN-CANCER
Authors: LANCASTER JM BERCHUCK A CARNEY ME WISEMAN R TAYLOR JA
Citation: Jm. Lancaster et al., PROGESTERONE-RECEPTOR GENE POLYMORPHISM AND RISK FOR BREAST AND OVARIAN-CANCER, British Journal of Cancer, 78(2), 1998, pp. 277-277
BRCA1 AND BRCA2 IN BREAST-CANCER FAMILIES FROM WALES - MODERATE MUTATION FREQUENCY AND 2 RECURRENT MUTATIONS IN BRCA1
Authors: LANCASTER JM CARNEY ME GRAY J MYRING J GUMBS C SAMPSON J WHEELER D FRANCE E WISEMAN R HARPER P FUTREAL PA
Citation: Jm. Lancaster et al., BRCA1 AND BRCA2 IN BREAST-CANCER FAMILIES FROM WALES - MODERATE MUTATION FREQUENCY AND 2 RECURRENT MUTATIONS IN BRCA1, British Journal of Cancer, 78(11), 1998, pp. 1417-1420
BRCA1 AND BRCA2 MUTATION SCREENING IN BREAST-CANCER FAMILIES
Authors: PHELAN CM LANCASTER JM GUMBS C DELOSRIOS P ABRAHAMSON J WARNER E PARFREY NA FUTREAL PA NAROD SA
Citation: Cm. Phelan et al., BRCA1 AND BRCA2 MUTATION SCREENING IN BREAST-CANCER FAMILIES, British Journal of Cancer, 78, 1998, pp. 35-35
DIDEOXY FINGERPRINTING ASSAY FOR BRCA1 MUTATION ANALYSIS
Authors: LANCASTER JM BERCHUCK A FUTREAL PA WISEMAN RW
Citation: Jm. Lancaster et al., DIDEOXY FINGERPRINTING ASSAY FOR BRCA1 MUTATION ANALYSIS, Molecular carcinogenesis, 19(3), 1997, pp. 176-179
DETECTION OF BRCA1 MUTATIONS IN WOMEN WITH EARLY-ONSET OVARIAN-CANCERBY USE OF THE PROTEIN TRUNCATION TEST
Authors: LANCASTER JM COCHRAN CJ BROWNLEE HA EVANS AC BERCHUCK A FUTREAL PA WISEMAN RW
Citation: Jm. Lancaster et al., DETECTION OF BRCA1 MUTATIONS IN WOMEN WITH EARLY-ONSET OVARIAN-CANCERBY USE OF THE PROTEIN TRUNCATION TEST, Journal of the National Cancer Institute, 88(8), 1996, pp. 552-554
MUTATION ANALYSIS OF THE BRCA2 GENE IN 49 SITE-SPECIFIC BREAST-CANCERFAMILIES (VOL 13, PG 120, 1996)
Authors: PHELAN CM LANCASTER JM TONIN P GUMBS C COCHRAN C CARTER R GHADIRIAN P PERRET C MOSLEHI R DION F FAUCHER MC DOLE K KARIMI S FOULKES W LOUNIS H WARNER E GOSS P ANDERSON D LARSSON C NAROD SA FUTREAL PA
Citation: Cm. Phelan et al., MUTATION ANALYSIS OF THE BRCA2 GENE IN 49 SITE-SPECIFIC BREAST-CANCERFAMILIES (VOL 13, PG 120, 1996), Nature genetics, 13(3), 1996, pp. 374-374
BRCA2 MUTATIONS IN PRIMARY BREAST AND OVARIAN CANCERS
Authors: LANCASTER JM WOOSTER R MANGION J PHELAN CM COCHRAN C GUMBS C SEAL S BARFOOT R COLLINS N BIGNELL G PATEL S HAMOUDI R LARSSON C WISEMAN RW BERCHUCK A IGLEHART JD MARKS JR ASHWORTH A STRATTON MR FUTREAL PA
Citation: Jm. Lancaster et al., BRCA2 MUTATIONS IN PRIMARY BREAST AND OVARIAN CANCERS, Nature genetics, 13(2), 1996, pp. 238-240
MUTATION ANALYSIS OF THE BRCA2 GENE IN 49 SITE-SPECIFIC BREAST-CANCERFAMILIES
Authors: PHELAN CM LANCASTER JM TONIN P GUMBS C COCHRAN C CARTER R GHADIRIAN P PERRET C MOSLEHI R DION F FAUCHER MC DOLE K KARIMI S FOULKES W LOUNIS H WARNER E GOSS P ANDERSON D LARSSON C NAROD SA FUTREAL PA
Citation: Cm. Phelan et al., MUTATION ANALYSIS OF THE BRCA2 GENE IN 49 SITE-SPECIFIC BREAST-CANCERFAMILIES, Nature genetics, 13(1), 1996, pp. 120-122
MICROSOMAL EPOXIDE HYDROLASE POLYMORPHISM AS A RISK FACTOR FOR OVARIAN-CANCER
Authors: LANCASTER JM BROWNLEE HA BELL DA FUTREAL PA MARKS JR BERCHUCK A WISEMAN RW TAYLOR JA
Citation: Jm. Lancaster et al., MICROSOMAL EPOXIDE HYDROLASE POLYMORPHISM AS A RISK FACTOR FOR OVARIAN-CANCER, Molecular carcinogenesis, 17(3), 1996, pp. 160-162
AN INEVITABLE DILEMMA - PRENATAL TESTING FOR MUTATIONS IN THE BRCA1 BREAST OVARIAN-CANCER SUSCEPTIBILITY GENE
Authors: LANCASTER JM WISEMAN RW BERCHUCK A
Citation: Jm. Lancaster et al., AN INEVITABLE DILEMMA - PRENATAL TESTING FOR MUTATIONS IN THE BRCA1 BREAST OVARIAN-CANCER SUSCEPTIBILITY GENE, Obstetrics and gynecology, 87(2), 1996, pp. 306-309
ROLE OF BRCA1 MUTATION SCREENING IN THE MANAGEMENT OF FAMILIAL OVARIAN-CANCER
Authors: BERCHUCK A CIRISANO F LANCASTER JM SCHILDKRAUT JM WISEMAN RW FUTREAL A MARKS JR
Citation: A. Berchuck et al., ROLE OF BRCA1 MUTATION SCREENING IN THE MANAGEMENT OF FAMILIAL OVARIAN-CANCER, American journal of obstetrics and gynecology, 175(3), 1996, pp. 738-746
P53 POLYMORPHISM IN OVARIAN AND BLADDER-CANCER
Authors: LANCASTER JM BROWNLEE HA WISEMAN RW TAYLOR J
Citation: Jm. Lancaster et al., P53 POLYMORPHISM IN OVARIAN AND BLADDER-CANCER, Lancet, 346(8968), 1995, pp. 182-182
USE OF GIS IN OPTIMIZING TIMBER THINNING STRATEGIES IN THE EASTERN SIERRA-NEVADA
Authors: KNAPP PA BISHOP KA LANCASTER JM TAYLOR RL
Citation: Pa. Knapp et al., USE OF GIS IN OPTIMIZING TIMBER THINNING STRATEGIES IN THE EASTERN SIERRA-NEVADA, The Professional geographer, 45(3), 1993, pp. 323-331
Risultati: 1-16 |